{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:44:22Z","timestamp":1792586662923,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"DOI":"10.1007\/s11739-026-04571-z","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:11:41Z","timestamp":1792584701000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between SGLT2 inhibitor use and functional outcomes in elderly patients receiving ferric carboxymaltose: a retrospective observational cohort study"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9775-9715","authenticated-orcid":false,"given":"Giuseppe","family":"Armentaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo Alberto","family":"Pastura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenica Maria","family":"Marino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giandomenico","family":"Severini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Maruca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentino","family":"Condoleo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Miceli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Maio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Andreozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Volterrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe Massimo Claudio","family":"Rosano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Sciacqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,21]]},"reference":[{"issue":"1","key":"4571_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/ejhf.2333","volume":"24","author":"TA McDonagh","year":"2022","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, ESC Scientific Document Group et al (2022) 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of cardiology (ESC). With the special contribution of the heart failure Association (HFA) of the ESC. Eur J Heart Fail. 24(1):4\u2013131. https:\/\/doi.org\/10.1002\/ejhf.2333. (PMID: 35083827)","journal-title":"Eur J Heart Fail."},{"issue":"8","key":"4571_CR2","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","volume":"147","author":"CW Tsao","year":"2023","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL et al (2023) Heart disease and stroke statistics\u20142023 update: a report from the American heart association. Circulation 147(8):e93\u2013e621. https:\/\/doi.org\/10.1161\/CIR.0000000000001123","journal-title":"Circulation"},{"issue":"1","key":"4571_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/ejhf.3024","volume":"26","author":"TA McDonagh","year":"2024","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, ESC Scientific Document Group (2024) Focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 26(1):5\u201317. https:\/\/doi.org\/10.1002\/ejhf.3024. (Epub 2024 Jan 3 PMID: 38169072)","journal-title":"Eur J Heart Fail."},{"issue":"1","key":"4571_CR4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1161\/CIRCHEARTFAILURE.109.865022","volume":"3","author":"A Pilotto","year":"2010","unstructured":"Pilotto A, Addante F, Franceschi M, Leandro G, Rengo G, D\u2019Ambrosio P et al (2010) Multidimensional Prognostic Index based on a comprehensive geriatric assessment predicts short-term mortality in older patients with heart failure. Circ Heart Fail. 3(1):14\u201320. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.109.865022","journal-title":"Circ Heart Fail."},{"issue":"4","key":"4571_CR5","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.arr.2011.03.003","volume":"10","author":"A Marengoni","year":"2011","unstructured":"Marengoni A, Angleman S, Melis R, Mangialasche F, Karp A, Garmen A et al (2011) Ageing with multimorbidity: a systematic review of the literature. Ageing Res Rev 10(4):430\u2013439. https:\/\/doi.org\/10.1016\/j.arr.2011.03.003. (Epub 23 March 2011 PMID: 21402176)","journal-title":"Ageing Res Rev"},{"issue":"1","key":"4571_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02949-5","volume":"24","author":"G Armentaro","year":"2025","unstructured":"Armentaro G, Vitale C, Cassano V, Magurno M, Panza A, Scarcelli MR, Pastura CA, Severini G, Mazza E, Hribal ML, Andreozzi F, Pujia A, Montalcini T, Rosano GMC, Sciacqua A (2025) Prognostic role of sarcopenia in heart failure patients. Cardiovasc Diabetol 24(1):411. https:\/\/doi.org\/10.1186\/s12933-025-02949-5","journal-title":"Cardiovasc Diabetol"},{"issue":"16","key":"4571_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25168811","volume":"25","author":"M Magurno","year":"2024","unstructured":"Magurno M, Cassano V, Maruca F, Pastura CA, Divino M, Fazio F, Severini G, Clausi E, Armentaro G, Miceli S, Maio R, Imbalzano E, Andreozzi F, Hribal ML, Sciacqua A (2024) Effects of SGLT2-inhibitors on comprehensive geriatric assessment, biomarkers of oxidative stress, and platelet activation in elderly diabetic patients with heart failure with preserved ejection fraction. Int J Mol Sci 25(16):8811. https:\/\/doi.org\/10.3390\/ijms25168811","journal-title":"Int J Mol Sci"},{"issue":"5","key":"4571_CR8","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s11739-024-03612-9","volume":"19","author":"G Armentaro","year":"2024","unstructured":"Armentaro G, Condoleo V, Pastura CA, Grasso M, Frasca A, Martire D, Cassano V, Maio R, Bonfrate L, Pastori D, Montalcini T, Andreozzi F, Sesti G, Violi F, Sciacqua A (2024) Prognostic role of serum albumin levels in patients with chronic heart failure. Intern Emerg Med. 19(5):1323\u20131333. https:\/\/doi.org\/10.1007\/s11739-024-03612-9. (Epub 2024 May 22. PMID: 38776047; PMCID: PMC11364577)","journal-title":"Intern Emerg Med."},{"issue":"4","key":"4571_CR9","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/ejhf.3262","volume":"26","author":"G Armentaro","year":"2024","unstructured":"Armentaro G, Cassano V, Condoleo V, Magurno M, Divino M, Pastura CA, Miceli S, Maio R, Arturi F, Hribal ML, Brunetti A, Sesti G, Rosano GMC, Sciacqua A (2024) Association of sodium-glucose cotransporter 2 inhibitors with changes in comprehensive geriatric assessment in elderly diabetic patients with heart failure: data from MAGIC-HF. Eur J Heart Fail 26(4):1095\u20131097. https:\/\/doi.org\/10.1002\/ejhf.3262","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"4571_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-025-03156-8","volume":"37","author":"G Armentaro","year":"2025","unstructured":"Armentaro G, Maio R, Bencivenga L, Okoye C, Severini G, Cassano V, Zanobbi V, Condoleo V, Bellelli G, Rengo G, Ungar A, Leosco D, Sciacqua A (2025) The use of SGLT2 inhibitors in older people: what is important? Aging Clin Exp Res 37(1):280. https:\/\/doi.org\/10.1007\/s40520-025-03156-8","journal-title":"Aging Clin Exp Res"},{"key":"4571_CR11","doi-asserted-by":"publisher","first-page":"164","DOI":"10.36150\/2499-6564-N932","volume":"73","author":"A Sciacqua","year":"2025","unstructured":"Sciacqua A, Armentaro G, Leosco D et al (2025) Iron deficiency in the elderly. Evidences from different clinical settings and efficacy of iron supplementation on outcomes. J Gerontol Geriatr. 73:164\u2013183. https:\/\/doi.org\/10.36150\/2499-6564-N932","journal-title":"J Gerontol Geriatr."},{"issue":"2","key":"4571_CR12","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.117.004519","volume":"11","author":"N Grote Beverborg","year":"2018","unstructured":"Grote Beverborg N, Klip IT, Meijers WC, Voors AA, Vegter EL, van der Wal HH et al (2018) Definition of iron deficiency based on the gold standard of bone marrow iron staining in heart failure patients. Circ Heart Fail 11(2):e004519. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.117.004519","journal-title":"Circ Heart Fail"},{"key":"4571_CR13","unstructured":"World Health Organisation (2011) Hemoglobin concentrations for the diagnosis of anemia and assessment of severity. Vitamin and Mineral Nutrition Information System. Geneva, World Health Organisation. (WHO\/NMH\/NHD\/MNM\/11.1)."},{"key":"4571_CR14","doi-asserted-by":"publisher","unstructured":"Camaschella C (2019) Iron deficiency. Blood. 3 January 133(1): 30\u201339. https:\/\/doi.org\/10.1182\/blood-2018-05-815944. Epub 6 November 2018. Erratum in: Blood. 9 February 2023;141(6):682. 10.1182\/blood.2022018610. PMID: 30401704.","DOI":"10.1182\/blood-2018-05-815944"},{"issue":"1","key":"4571_CR15","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1186\/s12872-020-01725-5","volume":"20","author":"IJ Fuentes-Abolafio","year":"2020","unstructured":"Fuentes-Abolafio IJ, Stubbs B, P\u00e9rez-Belmonte LM, Bernal-L\u00f3pez MR, G\u00f3mez-Huelgas R, Cuesta-Vargas AI (2020) Physical functional performance and prognosis in patients with heart failure: a systematic review and meta-analysis. BMC Cardiovasc Disord 20(1):512. https:\/\/doi.org\/10.1186\/s12872-020-01725-5","journal-title":"BMC Cardiovasc Disord"},{"key":"4571_CR16","doi-asserted-by":"publisher","DOI":"10.1177\/0898264312438551","author":"AN Freire","year":"2012","unstructured":"Freire AN, Guerra RO, Alvarado B, Guralnik JM, Zunzunegui MV (2012) Validity and reliability of the short physical performance battery in two diverse older adult populations in Quebec and Brazil. J Aging Heal. https:\/\/doi.org\/10.1177\/0898264312438551","journal-title":"J Aging Heal"},{"issue":"1","key":"4571_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2021-000759","volume":"9","author":"A Kumar","year":"2022","unstructured":"Kumar A, Sharma E, Marley A, Samaan MA, Brookes MJ (2022) Iron deficiency anemia: pathophysiology, assessment, practical management. BMJ Open Gastroenterol 9(1):e000759. https:\/\/doi.org\/10.1136\/bmjgast-2021-000759. (PMID:34996762;PMCID:PMC8744124)","journal-title":"BMJ Open Gastroenterol"},{"issue":"22","key":"4571_CR18","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1001\/jama.2025.3833","volume":"333","author":"SD Anker","year":"2025","unstructured":"Anker SD, Friede T, Butler J, Talha KM, Placzek M, Diek M et al (2025) Intravenous ferric carboxymaltose in heart failure with iron deficiency: the FAIR-HF2 DZHK05 randomised clinical trial. JAMA. 333(22):1965\u20131976. https:\/\/doi.org\/10.1001\/jama.2025.3833. (PMID: 40159390; PMCID: PMC11955906)","journal-title":"JAMA."},{"issue":"1","key":"4571_CR19","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1161\/CIRCHEARTFAILURE.109.865022","volume":"3","author":"A Pilotto","year":"2010","unstructured":"Pilotto A, Addante F, Franceschi M, Leandro G, Rengo G, D\u2019Ambrosio P et al (2010) Multidimensional prognostic index based on a comprehensive geriatric assessment predicts short-term mortality in older patients with heart failure. Circ Heart Fail 3(1):14\u201320","journal-title":"Circ Heart Fail"},{"issue":"17","key":"4571_CR20","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/j.jacc.2018.02.059","volume":"71","author":"EZ Gorodeski","year":"2018","unstructured":"Gorodeski EZ, Goyal P, Hummel SL, Krishnaswami A, Goodlin SJ, Hart LL et al (2018) Geriatric cardiology section leadership council, American College of cardiology domain management approach to heart failure in the geriatric patient: present and future. J Am Coll Cardiol. 71(17):1921\u20131936. https:\/\/doi.org\/10.1016\/j.jacc.2018.02.059. (PMID: 29699619; PMCID: PMC7304050)","journal-title":"J Am Coll Cardiol."},{"issue":"10369","key":"4571_CR21","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1016\/S0140-6736(22)02083-9","volume":"400","author":"PR Kalra","year":"2022","unstructured":"Kalra PR, Cleland JGF, Petrie MC, Thomson EA, Kalra PA, Squire IB et al (2022) Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial. Lancet 400(10369):2199\u20132209. https:\/\/doi.org\/10.1016\/S0140-6736(22)02083-9","journal-title":"Lancet"},{"issue":"10266","key":"4571_CR22","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/S0140-6736(20)32339-4","volume":"396","author":"P Ponikowski","year":"2020","unstructured":"Ponikowski P, Kirwan BA, Anker SD, McDonagh T, Dorobantu M, Drozdz J et al (2020) Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial. Lancet 396(10266):1895\u20131904. https:\/\/doi.org\/10.1016\/S0140-6736(20)32339-4","journal-title":"Lancet"},{"issue":"15","key":"4571_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26157533","volume":"26","author":"G Armentaro","year":"2025","unstructured":"Armentaro G, Cassano V, Loiacono P, Fuoco C, Severini G, Pastura CA, Panza A, Panza M, Mazza E, Miceli S, Pujia A, Montalcini T, Sciacqua A (2025) Early effect of supplementation with essential amino acids on cardiac performance in elderly patients with heart failure and sarcopenia. Int J Mol Sci 26(15):7533. https:\/\/doi.org\/10.3390\/ijms26157533","journal-title":"Int J Mol Sci"},{"issue":"21","key":"4571_CR24","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1161\/CIRCULATIONAHA.119.042375","volume":"140","author":"S Verma","year":"2019","unstructured":"Verma S, Mazer CD, Yan AT, Mason T, Garg V, Teoh H et al (2019) Effect of empagliflozin on left ventricular mass in patients with type 2 diabetes mellitus and coronary artery disease: the EMPA-HEART cardiolink-6 randomised clinical trial. Circulation. 140(21):1693\u20131702. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.042375. (Epub 22 August 2019 PMID: 31434508)","journal-title":"Circulation."},{"issue":"12","key":"4571_CR25","doi-asserted-by":"publisher","first-page":"844","DOI":"10.14740\/jocmr2760w","volume":"8","author":"M Sano","year":"2016","unstructured":"Sano M, Takei M, Shiraishi Y, Suzuki Y (2016) Increased hematocrit during sodium-glucose cotransporter 2 inhibitor therapy indicates recovery of tubulointerstitial function in diabetic kidneys. J Clin Med Res 8(12):844\u2013847. https:\/\/doi.org\/10.14740\/jocmr2760w","journal-title":"J Clin Med Res"},{"key":"4571_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12050937","volume":"12","author":"G Armentaro","year":"2024","unstructured":"Armentaro G, Pelaia C, Condoleo V, Severini G, Crudo G, De Marco M, Pastura CA, Tallarico V, Pezzella R, Aiello D et al (2024) Effect of SGLT2-inhibitors on polygraphic parameters in elderly patients affected by heart failure, type 2 diabetes mellitus, and sleep apnoea. Biomedicines 12:937. https:\/\/doi.org\/10.3390\/biomedicines12050937","journal-title":"Biomedicines"},{"issue":"48","key":"4571_CR27","doi-asserted-by":"publisher","first-page":"5027","DOI":"10.1093\/eurheartj\/ehad235","volume":"44","author":"M Packer","year":"2023","unstructured":"Packer M (2023) Mechanisms of enhanced renal and hepatic erythropoietin synthesis by sodium-glucose cotransporter 2 inhibitors. Eur Heart J 44(48):5027\u20135035. https:\/\/doi.org\/10.1093\/eurheartj\/ehad235","journal-title":"Eur Heart J"},{"issue":"1","key":"4571_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-016-0763-7","volume":"14","author":"R Pavasini","year":"2016","unstructured":"Pavasini R, Guralnik J, Brown JC, Di Bari M, Cesari M, Landi F et al (2016) Short physical performance battery and all-cause mortality: systematic review and meta-analysis. BMC Med 14(1):215. https:\/\/doi.org\/10.1186\/s12916-016-0763-7","journal-title":"BMC Med"},{"issue":"4","key":"4571_CR29","doi-asserted-by":"publisher","first-page":"e245135","DOI":"10.1001\/jamanetworkopen.2024.5135","volume":"7","author":"M Gao","year":"2024","unstructured":"Gao M, Bhatia K, Kapoor A, Badimon J, Pinney SP, Mancini DM et al (2024) SGLT2 inhibitors, functional capacity, and quality of life in patients with heart failure: a systematic review and meta-analysis. JAMA Netw Open 7(4):e245135. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.5135","journal-title":"JAMA Netw Open"},{"issue":"9","key":"4571_CR30","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1161\/HYPERTENSIONAHA.123.20598","volume":"80","author":"G Santulli","year":"2023","unstructured":"Santulli G, Varzideh F, Forzano I, Wilson S, Salemme L, de Donato A et al (2023) Functional and clinical importance of SGLT2-inhibitors in frailty: from the kidney to the heart. Hypertension 80(9):1800\u20131809. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.123.20598","journal-title":"Hypertension"},{"issue":"37","key":"4571_CR31","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.1093\/eurheartj\/ehae479","volume":"45","author":"S von Haehling","year":"2024","unstructured":"von Haehling S, Doehner W, Evertz R, Garfias-Veitl T, Derad C, Diek M et al (2024) Ferric carboxymaltose and exercise capacity in heart failure with preserved ejection fraction and iron deficiency: the FAIR-HFpEF trial. Eur Heart J 45(37):3789\u20133800. https:\/\/doi.org\/10.1093\/eurheartj\/ehae479","journal-title":"Eur Heart J"},{"key":"4571_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.709872","volume":"8","author":"C Rizzo","year":"2021","unstructured":"Rizzo C, Carbonara R, Ruggieri R, Passantino A, Scrutinio D (2021) Iron deficiency: a new target for patients with heart failure. Front Cardiovasc Med 8:709872. https:\/\/doi.org\/10.3389\/fcvm.2021.709872","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"4571_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinme.2024.100211","volume":"24","author":"AK Awad","year":"2024","unstructured":"Awad AK, Abdelgalil MS, Gonnah AR, Mouffokes A, Ahmad U, Awad AK et al (2024) Intravenous iron for acute and chronic heart failure with reduced ejection fraction (HFrEF) patients with iron deficiency: an updated systematic review and meta-analysis. Clin Med 24(3):100211. https:\/\/doi.org\/10.1016\/j.clinme.2024.100211","journal-title":"Clin Med"},{"issue":"21","key":"4571_CR34","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","volume":"381","author":"JJV McMurray","year":"2019","unstructured":"McMurray JJV, Solomon SD, Inzucchi SE, K\u00f8ber L, Kosiborod MN, Martinez FA et al (2019) Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med 381(21):1995\u20132008. https:\/\/doi.org\/10.1056\/NEJMoa1911303","journal-title":"N Engl J Med"},{"issue":"15","key":"4571_CR35","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","volume":"383","author":"M Packer","year":"2020","unstructured":"Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P et al (2020) Cardiovascular and renal outcomes with empagliflozin in heart failure. N Engl J Med 383(15):1413\u20131424. https:\/\/doi.org\/10.1056\/NEJMoa2022190","journal-title":"N Engl J Med"},{"issue":"1","key":"4571_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-025-04998-w","volume":"25","author":"SR Noumegni","year":"2025","unstructured":"Noumegni SR, Kaze AD, Fonarow GC, Echouffo-Tcheugui JB (2025) Body mass index, exercise capacity and functional status in chronic heart failure. BMC Cardiovasc Disord 25(1):524. https:\/\/doi.org\/10.1186\/s12872-025-04998-w","journal-title":"BMC Cardiovasc Disord"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-026-04571-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-026-04571-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-026-04571-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:11:43Z","timestamp":1792584703000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-026-04571-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,21]]},"references-count":36,"alternative-id":["4571"],"URL":"https:\/\/doi.org\/10.1007\/s11739-026-04571-z","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,21]]},"assertion":[{"value":"13 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed written consent was obtained from all participants.","order":2,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved on 17\/10\/2012 by the local Institutional Ethics Committees of University \u201cMagna Graecia\u201d of Catanzaro (code protocol number 2012.63) for CATAnzaro Metabolic Risk factors (CATAMERI) Study; and on 20\/10\/2022 by Comitato Etico \u201cArea Centro\u201d (2022.304) for the \"MAgna GraecIa evaluation of Comorbidities in patients with Heart Failure (MAGIC-HF) study; ClinicalTrials.gov Identifier: NCT05915364. All investigations were made in accordance with the principles of the Declaration of Helsinki.","order":3,"name":"Ethics","label":"Institutional review board statement","group":{"name":"EthicsHeading","label":"Declarations"}}]}}